Sepsis is undoubtedly the most frequent and most challenging disease encountered in critically ill patients. The common consensus defines sepsis as a dysregulated inflammatory response to an infectious agent. Because pre-clinical data suggested an overwhelming inflammatory response to be responsible for the clinical entity sepsis, numerous clinical trials have been instigated to counteract the inflammatory response over the last 30 years. It is well known that basically none of these trials showed convincing (if at all) beneficial effects.Since it has been accepted that simply blocking single pathways such as TNF-a, does not suffice to treat sepsis, the number of clinical trials has dropped significantly. At the same time it was increasingly appreciated that sepsis is far more complex and underlying mechanisms involve multiple, often parallel pathways. As such this special issue of the WMW addresses recent advances in sepsis research by focusing on five targets: vagus nerve, mitochondrial function, activation of coagulation, obesity and metabolism and Toll-like receptors.Knapp, in her article, summarizes important aspects of Toll-like receptor (TLR) associated research [1]. In fact, the identification of TLRs at the end of the last century boosted the research in innate immunity and bacterial infections and definitely broadened our understanding of underlying mechanisms and pathways involved. The entire field is certainly beyond the scope of this article and Sylvia Knapp therefore focused on clinical aspects, explains currents therapeutic trials and highlights the role of TLRs in recognition of endogenous danger signals.Van Westerloo describes in his article the role of the vagus nerve upon activation of the innate immune response during infection or injury [2]. Recently, a neural circuit involving the vagus nerve has been identified that controls the inflammatory response in a reflex-like manner. This circuit is able to sense inflammation and to respond by releasing acetylcholine which, through the interaction with immune cells, dampens the inflammatory response. These findings remind us of an article by Tracey entitled mind over immunity in 2001, which suggests that the central nervous system regulates the innate immune system by elaborating anti-inflammatory hormone cascades in response to bacterial products and immune mediators. The authors discovered that the central nervous system also responds via acetylcholine-mediated efferent signals carried through the vagus nerve. Nicotinic cholinergic receptors expressed on macrophages detect these signals and respond by dampening the cytokine response. Conversely, vagus nerve stimulators can mimic this response and can prevent lethal endotoxemia. This newly appreciated cholinergic anti-inflammatory pathway provides a neural substrate to study brain-immune interactions and might be harnessed for the therapy of cytokine-mediated disease.Wendel and Heller focus on the role of mitochondria as the key-source of cellular energy provided by ATP [3]. The structure and funct...